Seattle life science companies raised only $395.9 million through the third quarter, on pace for the weakest year since at least 2022, as Savills' Q3 2026 data show vacancy rising 150 basis points to 18.9 percent while Bay Area funding and vacancy hold steadier.
Thank you for your interest in The Registry. If you'd like to read further, you must Subscribe or Log In below to read the rest of this content.

Signup for news and special announcements!
You have successfully joined our subscriber list.
Metro is redirecting interest earned on its $652.8 million housing bond to...
ByThe RegistryNovember 3, 2026Carlsbad, Calif.-based niche perfumery The Drydown has signed on for the second...
ByThe RegistryNovember 3, 2026Nuveen Real Estate has acquired a 13-property open-air retail portfolio spanning Washington,...
ByThe RegistryNovember 3, 2026Construction is underway on the first 239 apartments of a 400-unit, $170...
ByThe RegistryNovember 3, 2026